Read + Share
Amedeo Smart
Independent Medical Education
Chan CY, Yuen VW, Chiu DK, Goh CC, et al. Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity. Hepatology 2023;77:729-744.PMID: 35302667
Email
LinkedIn
Facebook
Twitter
Privacy Policy